Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- Real Time PCR, Digital PCR, And End Point PCR Market Outlook
- In Vitro Diagnostics
Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the real time pcr, digital pcr, and end point pcr market
Italy real time pcr, digital pcr, and end point pcr market highlights
- The Italy real time pcr, digital pcr, and end point pcr market generated a revenue of USD 277.1 million in 2023 and is expected to reach USD 257.3 million by 2030.
- The Italy market is expected to grow at a CAGR of -1.1% from 2024 to 2030.
- In terms of segment, quantitative was the largest revenue generating technology in 2023.
- Digital is the most lucrative technology segment registering the fastest growth during the forecast period.
Real time pcr, digital pcr, and end point pcr market data book summary
| Market revenue in 2023 | USD 277.1 million |
| Market revenue in 2030 | USD 257.3 million |
| Growth rate | -1.1% (CAGR from 2023 to 2030) |
| Largest segment | Quantitative |
| Fastest growing segment | Digital |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Quantitative, Digital, End-point |
| Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
Other key industry trends
- In terms of revenue, Italy accounted for 3.6% of the global real time pcr, digital pcr, and end point pcr market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK real time pcr, digital pcr, and end point pcr market is projected to lead the regional market in terms of revenue in 2030.
- Norway is the fastest growing regional market in Europe and is projected to reach USD 31.4 million by 2030.
Companies specializing in RT-PCR, dPCR, and end-point solutions are actively seeking distribution agreements with local partners to expand their presence in the market. For instance, SML Genetree entered a distribution agreement with TEMA Ricerca Srl. to distribute NGS kits and Ezplex PCR.
In addition, in February 2022, Cerca Biotech entered into a distribution deal with four European partners for MammaTyper, an RT-qPCR diagnostic test for breast cancer diagnosis.
The distribution agreement covers European countries, including Germany, France, Italy, and the UK. The deal facilitates the adoption of PCR products due to the improved availability of consumables, reagents, and instruments in the market.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real Time PCR, Digital PCR, And End Point PCR Market Scope
Real Time PCR, Digital PCR, And End Point PCR Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| GE Aerospace | View profile | 125,000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | www.geaerospace.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Fluidigm Corporation | View profile | 501-1000 | South San Francisco, California, United States, North America | www.fluidigm.com |
Italy Real Time PCR, Digital PCR, And End Point PCR Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Real Time PCR, Digital PCR, And End Point PCR Market Outlook will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 84.81% in 2023.
Horizon Databook has segmented the Italy real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Companies specializing in RT-PCR, dPCR, and end-point solutions are actively seeking distribution agreements with local partners to expand their presence in the market. For instance, SML Genetree entered a distribution agreement with TEMA Ricerca Srl. to distribute NGS kits and Ezplex PCR.
In addition, in February 2022, Cerca Biotech entered into a distribution deal with four European partners for MammaTyper, an RT-qPCR diagnostic test for breast cancer diagnosis.
The distribution agreement covers European countries, including Germany, France, Italy, and the UK. The deal facilitates the adoption of PCR products due to the improved availability of consumables, reagents, and instruments in the market.
- Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market Technology Outlook (Revenue, USD Million , 2018-2030)
- Quantitative
- Digital
- End-point
- Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market Product Outlook (Revenue, USD Million , 2018-2030)
- Consumables & Reagents
- Instruments
- Software & Services
- Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market Application Outlook (Revenue, USD Million , 2018-2030)
- Clinical
- Research
- Forensic
Reasons to subscribe to Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Real Time PCR, Digital PCR, And End Point PCR Market Outlook databook
- Our clientele includes a mix of Real Time PCR, Digital PCR, And End Point PCR Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Real Time PCR, Digital PCR, And End Point PCR Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Real Time PCR, Digital PCR, And End Point PCR Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Italy Real Time Pcr, Digital Pcr, And End Point Pcr Market, 2018-2030 (US$M)
Italy real time pcr, digital pcr, and end point pcr market statistics, by technology, 2018-2030 (US$M)
